Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$1.16
-0.0600 (-4.92%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.90 $1.74 Friday, 10th May 2024 FGEN stock ended at $1.16. This is 4.92% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.04% from a day low at $1.12 to a day high of $1.21.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Jan 04, 2017 $21.35 $23.00 $21.35 $22.90 579 928
Jan 03, 2017 $21.50 $22.10 $20.95 $21.30 402 773
Dec 30, 2016 $21.75 $22.10 $21.20 $21.40 284 509
Dec 29, 2016 $20.85 $21.80 $20.85 $21.75 402 228
Dec 28, 2016 $20.40 $20.90 $20.25 $20.85 387 400
Dec 27, 2016 $20.90 $21.33 $20.25 $20.25 287 709
Dec 23, 2016 $19.55 $20.95 $19.55 $20.80 259 033
Dec 22, 2016 $19.95 $20.25 $19.25 $19.50 301 323
Dec 21, 2016 $20.25 $20.40 $19.60 $19.80 315 517
Dec 20, 2016 $20.25 $20.50 $20.05 $20.10 293 941
Dec 19, 2016 $20.60 $21.25 $19.90 $20.05 311 821
Dec 16, 2016 $21.20 $21.70 $20.25 $20.45 593 334
Dec 15, 2016 $20.45 $21.15 $19.95 $21.15 360 708
Dec 14, 2016 $20.65 $21.00 $19.81 $20.35 381 267
Dec 13, 2016 $21.45 $21.65 $20.45 $20.65 298 328
Dec 12, 2016 $22.05 $22.25 $21.00 $21.20 360 607
Dec 09, 2016 $22.70 $23.25 $22.15 $22.35 256 327
Dec 08, 2016 $22.05 $22.55 $21.40 $22.55 406 238
Dec 07, 2016 $22.20 $22.40 $21.42 $22.30 470 922
Dec 06, 2016 $22.30 $22.80 $22.00 $22.65 323 524
Dec 05, 2016 $21.55 $22.30 $21.10 $22.25 355 631
Dec 02, 2016 $20.75 $21.45 $20.65 $21.25 263 446
Dec 01, 2016 $22.25 $22.45 $20.40 $20.55 527 960
Nov 30, 2016 $23.15 $23.40 $22.10 $22.15 315 275
Nov 29, 2016 $22.80 $23.20 $22.50 $22.90 316 469
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT